Novartis AG ADR buy The Goldman Sachs Group, Inc.
Start price
30.05.24
/
50%
€92.80
Target price
30.05.25
€110.78
Performance (%)
9.91%
End price
31.05.25
€102.00
Summary
This prediction ended on 31.05.25 with a price of €102.00. The BUY prediction by The_Goldman_Sachs_Gr finished with a performance of 9.91%. The_Goldman_Sachs_Gr has a follow-up prediction for Novartis AG ADR, but this time predicts that Novartis AG ADR is a Sell. A total of €3.87 was paid as dividends for this prediction. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novartis AG ADR | 0.000% | 0.000% | 25.530% |
| iShares Core DAX® | 0.794% | 2.841% | 22.630% |
| iShares Nasdaq 100 | 0.016% | -0.939% | 6.943% |
| iShares Nikkei 225® | 0.309% | -0.648% | 13.619% |
| iShares S&P 500 | 0.181% | -0.442% | 4.692% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Novartis AG ADR diskutieren
Novartis AG (NYSE: NVS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $120.00 price target on the stock.
Ratings data for NVS provided by MarketBeat
In the thread Trading Novartis AG ADR
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by The_Goldman_Sachs_Gr for Novartis AG ADR
Novartis AG ADR
Start price
Target price
Perf. (%)
€106.50
12.09.25
12.09.25
€100.61
12.09.26
12.09.26
11.27%
30.12.25
30.12.25
